vs
Side-by-side financial comparison of Aeries Technology, Inc. (AERT) and Astrana Health, Inc. (ASTH). Click either name above to swap in a different company.
Astrana Health, Inc. is the larger business by last-quarter revenue ($950.5M vs $17.5M, roughly 54.4× Aeries Technology, Inc.). Aeries Technology, Inc. runs the higher net margin — 6.6% vs 0.7%, a 5.9% gap on every dollar of revenue. On growth, Astrana Health, Inc. posted the faster year-over-year revenue change (42.9% vs -0.8%). Aeries Technology, Inc. produced more free cash flow last quarter ($2.1M vs $-6.0M). Over the past eight quarters, Astrana Health, Inc.'s revenue compounded faster (53.3% CAGR vs -5.9%).
Astrana Health, Inc. is a U.S.-based value-based healthcare services provider that primarily serves Medicare-eligible senior populations across the United States. It offers in-home primary care, chronic disease management, and care coordination services, aiming to improve patient health outcomes and reduce unnecessary medical costs.
AERT vs ASTH — Head-to-Head
Income Statement — Q3 2026 vs Q4 2025
| Metric | | |
|---|---|---|
| Revenue | $17.5M | $950.5M |
| Net Profit | $1.2M | $6.6M |
| Gross Margin | 19.1% | — |
| Operating Margin | 4.4% | 1.9% |
| Net Margin | 6.6% | 0.7% |
| Revenue YoY | -0.8% | 42.9% |
| Net Profit YoY | -56.7% | 184.4% |
| EPS (diluted) | $0.02 | $0.12 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $17.5M | $950.5M | ||
| Q3 25 | $17.4M | $956.0M | ||
| Q2 25 | $15.3M | $654.8M | ||
| Q1 25 | $19.1M | $620.4M | ||
| Q4 24 | $17.6M | $665.2M | ||
| Q3 24 | $16.9M | $478.7M | ||
| Q2 24 | $16.7M | $486.3M | ||
| Q1 24 | $19.7M | $404.4M |
| Q4 25 | $1.2M | $6.6M | ||
| Q3 25 | $369.0K | $373.0K | ||
| Q2 25 | $1.6M | $9.4M | ||
| Q1 25 | $-6.0M | $6.7M | ||
| Q4 24 | $2.7M | $-7.8M | ||
| Q3 24 | $-2.3M | $16.1M | ||
| Q2 24 | $-14.7M | $19.2M | ||
| Q1 24 | $32.1M | $14.8M |
| Q4 25 | 19.1% | — | ||
| Q3 25 | 28.9% | — | ||
| Q2 25 | 24.6% | — | ||
| Q1 25 | 26.7% | — | ||
| Q4 24 | 23.0% | — | ||
| Q3 24 | 21.2% | — | ||
| Q2 24 | 24.1% | — | ||
| Q1 24 | 32.1% | — |
| Q4 25 | 4.4% | 1.9% | ||
| Q3 25 | 11.4% | 2.0% | ||
| Q2 25 | 5.3% | 3.1% | ||
| Q1 25 | -16.3% | 3.3% | ||
| Q4 24 | -29.3% | 0.1% | ||
| Q3 24 | -24.3% | 5.9% | ||
| Q2 24 | -98.5% | 6.2% | ||
| Q1 24 | -0.0% | 7.5% |
| Q4 25 | 6.6% | 0.7% | ||
| Q3 25 | 2.1% | 0.0% | ||
| Q2 25 | 10.3% | 1.4% | ||
| Q1 25 | -31.6% | 1.1% | ||
| Q4 24 | 15.2% | -1.2% | ||
| Q3 24 | -13.5% | 3.4% | ||
| Q2 24 | -87.9% | 3.9% | ||
| Q1 24 | 163.1% | 3.7% |
| Q4 25 | $0.02 | $0.12 | ||
| Q3 25 | $0.01 | $0.01 | ||
| Q2 25 | $0.03 | $0.19 | ||
| Q1 25 | $-0.10 | $0.14 | ||
| Q4 24 | $0.08 | $-0.14 | ||
| Q3 24 | $-0.05 | $0.33 | ||
| Q2 24 | $-0.39 | $0.40 | ||
| Q1 24 | — | $0.31 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $2.6M | $429.5M |
| Total DebtLower is stronger | $943.0K | — |
| Stockholders' EquityBook value | $-1.2M | $779.3M |
| Total Assets | $42.0M | $2.2B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $2.6M | $429.5M | ||
| Q3 25 | $1.9M | $463.4M | ||
| Q2 25 | $2.1M | $342.1M | ||
| Q1 25 | $2.8M | $260.9M | ||
| Q4 24 | $2.4M | $290.8M | ||
| Q3 24 | $3.6M | $350.3M | ||
| Q2 24 | $4.2M | $327.7M | ||
| Q1 24 | $2.1M | $337.3M |
| Q4 25 | $943.0K | — | ||
| Q3 25 | $960.0K | — | ||
| Q2 25 | $1.1M | — | ||
| Q1 25 | $1.1M | — | ||
| Q4 24 | $1.5M | — | ||
| Q3 24 | $1.5M | — | ||
| Q2 24 | $1.7M | — | ||
| Q1 24 | $1.5M | — |
| Q4 25 | $-1.2M | $779.3M | ||
| Q3 25 | $-2.9M | $775.5M | ||
| Q2 25 | $-4.3M | $765.5M | ||
| Q1 25 | $-5.8M | $745.4M | ||
| Q4 24 | $692.0K | $712.7M | ||
| Q3 24 | $-2.3M | $704.6M | ||
| Q2 24 | $-231.0K | $678.9M | ||
| Q1 24 | $-12.2M | $653.5M |
| Q4 25 | $42.0M | $2.2B | ||
| Q3 25 | $40.5M | $2.2B | ||
| Q2 25 | $38.8M | $1.4B | ||
| Q1 25 | $39.8M | $1.3B | ||
| Q4 24 | $50.7M | $1.4B | ||
| Q3 24 | $52.0M | $1.3B | ||
| Q2 24 | $51.8M | $1.3B | ||
| Q1 24 | $49.4M | $1.2B |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 2.17× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $2.4M | $-2.9M |
| Free Cash FlowOCF − Capex | $2.1M | $-6.0M |
| FCF MarginFCF / Revenue | 12.2% | -0.6% |
| Capex IntensityCapex / Revenue | 1.3% | 0.3% |
| Cash ConversionOCF / Net Profit | 2.05× | -0.44× |
| TTM Free Cash FlowTrailing 4 quarters | $4.6M | $104.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $2.4M | $-2.9M | ||
| Q3 25 | $1.0M | $10.0M | ||
| Q2 25 | $1.4M | $90.9M | ||
| Q1 25 | $864.0K | $16.6M | ||
| Q4 24 | $-2.1M | $-10.9M | ||
| Q3 24 | $1.9M | $34.0M | ||
| Q2 24 | $-1.7M | $23.2M | ||
| Q1 24 | $-3.0M | $6.0M |
| Q4 25 | $2.1M | $-6.0M | ||
| Q3 25 | $653.0K | $7.4M | ||
| Q2 25 | $1.1M | $89.5M | ||
| Q1 25 | $752.0K | $13.6M | ||
| Q4 24 | $-2.5M | $-13.5M | ||
| Q3 24 | $1.3M | $31.7M | ||
| Q2 24 | $-2.1M | $20.4M | ||
| Q1 24 | $-3.5M | $5.6M |
| Q4 25 | 12.2% | -0.6% | ||
| Q3 25 | 3.8% | 0.8% | ||
| Q2 25 | 7.2% | 13.7% | ||
| Q1 25 | 3.9% | 2.2% | ||
| Q4 24 | -14.0% | -2.0% | ||
| Q3 24 | 7.8% | 6.6% | ||
| Q2 24 | -12.5% | 4.2% | ||
| Q1 24 | -17.6% | 1.4% |
| Q4 25 | 1.3% | 0.3% | ||
| Q3 25 | 2.1% | 0.3% | ||
| Q2 25 | 1.7% | 0.2% | ||
| Q1 25 | 0.6% | 0.5% | ||
| Q4 24 | 2.2% | 0.4% | ||
| Q3 24 | 3.6% | 0.5% | ||
| Q2 24 | 2.2% | 0.6% | ||
| Q1 24 | 2.3% | 0.1% |
| Q4 25 | 2.05× | -0.44× | ||
| Q3 25 | 2.78× | 26.69× | ||
| Q2 25 | 0.87× | 9.65× | ||
| Q1 25 | — | 2.48× | ||
| Q4 24 | -0.78× | — | ||
| Q3 24 | — | 2.11× | ||
| Q2 24 | — | 1.21× | ||
| Q1 24 | -0.09× | 0.40× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AERT
Segment breakdown not available.
ASTH
| Medicare | $542.4M | 57% |
| Commercial | $99.1M | 10% |
| Care Delivery | $92.1M | 10% |
| Care Enablement | $78.9M | 8% |
| Other Third Parties | $58.0M | 6% |
| Health Care Patient Service | $39.8M | 4% |
| Health Care Other | $25.5M | 3% |
| Other | $12.1M | 1% |
| Management Service | $10.3M | 1% |
